Maria M. Sukhova

Maria M. Sukhova

Auto-generated profile, based on publicly available information

Maria M. Sukhova

National Research Center – Institute of Immunology of the Federal Medical-Biological Agency, Moscow

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Immunologiya
Verified
Journal Article
Open access
MBMaria Byazrova
Maria Byazrova
APA.S. Poroshina
A.S. Poroshina
MSM.M. Sukhova
M.M. Sukhova
EFE.A. Frolov
E.A. Frolov
ASA.B. Shilkina
A.B. Shilkina
AFAlexander V Filatov
Alexander V Filatov
Продукция цитокинов наивными В-лимфоцитами и В-клетками памяти при стимуляции in vitro

21 October 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
AVAnna Vladimirovna Vakhrusheva
Anna Vladimirovna Vakhrusheva
EREkaterina Andreevna Romanovskaya-Romanko
Ekaterina Andreevna Romanovskaya-Romanko
SMStukova Marina
Stukova Marina
MSMaria M. Sukhova
Maria M. Sukhova
KKKsenia Kuznetsova
Ksenia Kuznetsova
AIArtur Isaev
Artur Isaev
SARS-CoV-2, the causal agent of the COVID-19 pandemic, is characterized by rapid evolution, which poses a significant public health challenge. Effective vaccines that provide robust protection, elicit strong immune responses, exhibit favorable safety profiles, and enable cost-effective large-scale production are crucial. The RBD-Fc-based Betuvax-CoV-2 vaccine has previously demonstrated a favorable safety profile and induced a significant anti-SARS-CoV-2 humoral immune response in clinical trials. Due to the rapid evolution and emergence of new SARS-CoV-2 strains, the relevance of bivalent vaccine formulations has increased. Methods: This study compared the neutralizing capacity of monovalent and bivalent vaccine formulations against different SARS-CoV-2 strains detected with a SARS-CoV-2 microneutralization assay (MNT). Findings: The monovalent Wuhan-based vaccine generated neutralizing antibodies against the Wuhan and Omicron BA.2 variants but not the distinct Omicron BQ.1 strain. Conversely, the monovalent BA.2-based vaccine induced neutralizing antibodies against both Omicron strains but not Wuhan. While the bivalent Wuhan and BA.2-based vaccine was effective against strains containing the same antigens, it was insufficient to neutralize the distinctive BQ.1 strain at a small dosage. Interpretation: These findings suggest that the vaccine composition should closely match the circulating SARS-CoV-2 strain to elicit the optimal neutralizing antibody response and include the appropriate dosage. Moreover, this study did not find additional advantages of using the bivalent form over the monovalent form for the vaccination against a single prevailing SARS-CoV-2 strain.

1 January 2023 in Immunologiya
Verified
Journal Article
Open access
MBMaria Byazrova
Maria Byazrova
AMA.A. Mikhailov
A.A. Mikhailov
MSM.M. Sukhova
M.M. Sukhova
APA.G. Prilipov
A.G. Prilipov
AFAlexander V Filatov
Alexander V Filatov
Биохимическая и функциональная характеристика мультимеризованных белков, содержащих рецепторный домен CD40L

1 January 2023 in Immunologiya
Verified
Journal Article
Open access
MBMaria Byazrova
Maria Byazrova
AMA.A. Mikhailov
A.A. Mikhailov
MSM.M. Sukhova
M.M. Sukhova
MBMaryana V Bardina
Maryana V Bardina
MLMoscow Marlin Biotech Llc
Moscow Marlin Biotech Llc
AFAlexander V Filatov
Alexander V Filatov
Трансдукция В-лимфоцитов человека с помощью аденоассоциированных вирусов различных серотипов

1 January 2025 in Immunologiya
Verified
Journal Article
Open access
MSM.M. Sukhova
M.M. Sukhova
MBMaria Byazrova
Maria Byazrova
PGP.P. Guseva
P.P. Guseva
AMA.A. Mikhailov
A.A. Mikhailov
TTT.D. Tsoy
T.D. Tsoy
AFAlexander V Filatov
Alexander V Filatov
Линия сенсорных клеток для определения активности препаратов растворимого CD40L

1 January 2026 in Immunologiya
Verified
Journal Article
Closed access
MSM.M. Sukhova
M.M. Sukhova
MBMaria Byazrova
Maria Byazrova
ANA.E. Nikonova
A.E. Nikonova
TTT.D. Tsoy
T.D. Tsoy
PGP.P. Guseva
P.P. Guseva
AFAlexander V Filatov
Alexander V Filatov